Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Piana

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Clinical Pharmacology|October 15, 2013
Covariate effects and population pharmacokinetics of lamivudine in HIV-infected childrenChiara Piana, Wei Zhao, Kimberly Adkison, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 16, 2023
Model-based prediction of effective target exposure for MEN1611 in combination with trastuzumab in HER2-positive advanced or metastatic breast cancer patientsElena M Tosca, Elisa Borella, Chiara Piana, et al.
European Journal of Clinical Pharmacology|March 27, 2010
The role of population PK-PD modelling in paediatric clinical researchRoosmarijn F W De Cock, Chiara Piana, Elke H J Krekels, et al.
British Journal of Clinical Pharmacology|September 27, 2024
Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK<sub>2</sub> receptors, in infants with colicSiv Jönsson, Salim Bouchene, Paolo Mazzei, et al.
Journal of Clinical Pharmacology|May 14, 2011
Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseasesChiara Piana, Linda Surh, Sabine Furst-Recktenwald, et al.
British Journal of Clinical Pharmacology|June 26, 2024
Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram-negative bacterial infectionsChiara Fornari, Antonio Arrieta, John S Bradley, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Clinical Pharmacology|October 15, 2013
Covariate effects and population pharmacokinetics of lamivudine in HIV-infected childrenChiara Piana, Wei Zhao, Kimberly Adkison, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 16, 2023
Model-based prediction of effective target exposure for MEN1611 in combination with trastuzumab in HER2-positive advanced or metastatic breast cancer patientsElena M Tosca, Elisa Borella, Chiara Piana, et al.
European Journal of Clinical Pharmacology|March 27, 2010
The role of population PK-PD modelling in paediatric clinical researchRoosmarijn F W De Cock, Chiara Piana, Elke H J Krekels, et al.
British Journal of Clinical Pharmacology|September 27, 2024
Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK<sub>2</sub> receptors, in infants with colicSiv Jönsson, Salim Bouchene, Paolo Mazzei, et al.
Journal of Clinical Pharmacology|May 14, 2011
Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseasesChiara Piana, Linda Surh, Sabine Furst-Recktenwald, et al.
British Journal of Clinical Pharmacology|June 26, 2024
Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram-negative bacterial infectionsChiara Fornari, Antonio Arrieta, John S Bradley, et al.
Pageof 2